Memantine Canon, 20 mg 30 pcs

Concussion and other brain injuries, Alcoholism, Stroke sequelae, Alzheimer’s disease, Attention and memory disorders, Acquired dementiaModerate to severe Alzheimer’s dementia.

Active ingredient

How to take, the dosage

Interaction

Special Instructions

Contraindications

Side effects

Overdose

In the ongoing clinical studies and post-marketing study of Memantine Canon, limited information has been received about overdoses.

Symptoms: In sufficiently large overdoses (200 mg once or more than 100 mg per day for 3 days) the following symptoms have been identified: weakness, fatigue, diarrhea, or no symptoms. In overdose of less than 140 mg or in unknown overdose, the following adverse events have been identified from the nervous system: confusion, drowsiness, dizziness, agitation, aggression, hallucinations and gait disturbance and from the gastrointestinal tract: vomiting and diarrhea.

In the most serious cases of overdose, the patient survived after taking more than 2000 mg of memantine with adverse nervous system events (coma for 10 days, diplopia, agitation). The patient received symptomatic therapy and plasmapheresis and recovered without any sequelae.

The other case of a serious overdose described was 400 mg once. The patient recovered without consequences. Nervous system reactions were noted: anxiety, psychosis, visual hallucinations, stupor, drowsiness, unconsciousness.
Treatment: in case of overdose symptomatic treatment is necessary. There is no specific antidote for memantine intoxication. Standard procedures for evacuation of the drug by irrigation, the use of activated charcoal, forced diuresis, means of alkalizing the urine should be carried out.

If symptoms of central nervous system overexcitation occur, symptomatic therapy should be selected with extreme care.

Similarities